Mouse fibroblasts (3T3-L1 cells) accumulate detergent-and salt-insoluble aggregates of proteins conjugated to ubiquitin when incubated in the presence of inhibitors of lysosomal cysteine cathepsins, including E-64. These ubiquitin-protein conjugates co-fractionate with lysosomes on density gradients and are found in multivesicular dense bodies which by electron microscopy appear to be engaged in microautophagy. Both E-64 and ammonium chloride increase the intracellular concentration of free ubiquitin, but only E-64 leads to the formation of insoluble lysosomal ubiquitin-protein conjugates. The results are discussed in relation to the possible intracellular roles of ubiquitin conjugation.
INTRODUCTION
Ubiquitin is a small protein which has been implicated as a cofactor in the non-lysosomal rapid turnover of some short-lived and abnormal proteins by a soluble proteinase of high molecular mass (Ciechanover et al., 1984; Hough et al., 1987) . Some ubiquitin-protein conjugates, however, have been found to be relatively stable in human lung fibroblasts (Haas & Bright, 1987) and may not be good substrates for the ATP-dependent proteinase of high molecular mass which degrades the substrate protein of ubiquitin conjugates in the cytosol (Hough et al., 1987; McGuire et al., 1988) . Ubiquitin is also found conjugated to various plasma membrane proteins (Siegelman et al., 1986; Yarden et al., 1986; Meyer et al., 1986) and the turnover of plasma membrane proteins is thought to occur in the lysosome (Tweto & Doyle, 1976; Fernig & Mayer, 1987) . In addition, we have found that ubiquitin immunoreactivity coincides with areas of granulovacuolar degeneration in Alzheimer's disease (Lowe et al., 1988a) . Ubiquitin has been found to be released into the medium from cells in tissue culture Haas & Bright, 1987) and recently free ubiquitin has been located in lysosomes and autophagic vacuoles of hepatoma cells by immunogold electron microscopy (Schwartz et al., 1988) . These observations suggest that ubiquitin and ubiquitin-protein conjugates may be found in the intravesicular spaces of the cell as well as in the cytosol. We report here that treatment of cells with inhibitors of lysosomal cathepsins, in particular the membrane-impermeant (Shoji-Kasai et al., 1988) inhibitor of cysteine cathepsins, E-64, leads to the accumulation of multivesicular bodies containing proteins conjugated to ubiquitin.
MATERIALS AND METHODS Materials
Epoxysuccinyl-leucylamido-(4-guanidino)butane (E-64) , antipain, leupeptin and Z-Phe-Arg-7-aminomethylcoumarin were obtained from Cambridge Research Biochemicals (Cambridge, U.K.). Z-Phe-Ala-CHN2 and ZPhe-Phe-CHN2 were the generous gift of Dr. E. Shaw, Friedrich Miescher-Institut, Basle, Switzerland. Nitro- cellulose (0.45 /tm) was obtained from Schleicher and Schuell (Dassel, Germany) and 0.2,um from Sigma (Poole, U.K.). Biotinylated antibodies, avidin and biotinylated alkaline phosphatase were supplied by Vector Laboratories (Peterborough, U.K.). Radiochemicals were supplied by Amersham International plc (Amersham, U.K.). Scintillation fluid was LKB 'Optiphase X' manufactured by FSA Laboratory Supplies (Loughborough, U.K.). Affi-Sep affinity matrix was supplied by Anachem (Luton, Beds., U.K.). Bovine erythrocyte ubiquitin, streptavidin-gold and hydroxysuccinimide-activated Sepharose were from Sigma. Other chemicals were obtained as described previously (Doherty et al., 1987) . Lowicryl was supplied by TAAB Laboratories (Aldermaston, U.K.).
Protein degradation
3T3-L1 fibroblasts were cultured and used at confluency as described previously (Doherty et al., 1987) , except that stock cultures were grown in antibioticfree medium. Cells were pulse-labelled for 48 h with either [3H]methionine or [3H]leucine (1-5 ,Ci/ml) in Dulbecco's modification of Eagle's medium containing either 50 4uM-methionine or 100,uM-leucine, depending on the radiolabelled amino acid employed, as well as new-born calf serum (10 0%, v/v), gentamycin (50 mg/l) and amphotericin (2.5 mg/l). After the labelling period, cells were subcultured into multiwell plates and chased for 16 h in chase medium containing either 10 mM-leucine or 10 mM-methionine, depending on the radiolabelled amino acid used, to remove short-lived labelled polypeptides, and then chased again (48 h) in fresh chase medium in the presence or absence of proteolytic inhibitors. Controls for the effects of these agents consisted of cells chased with the appropriate concentration of solvent diluted in chase medium. Protein degradation rates were calculated as described previously (Doherty et al., 1987) . Inhibition of protein degradation was calculated from the rate constant of degradation (kd) for control and inhibitor-treated cells, i.e. inhibition (%) =[(kd, control -kd, inhibitor)/kd, control] X 100.
Detergent and salt extraction of cells
Sequential extraction of 3T3-L1 cells with detergent and salt was carried out as described previously (Doherty et al., 1987) , except that the Triton extraction medium [Triton X-100 (1 %, v/v) in 100 mM-Hepes, 2 mMmagnesium chloride, pH 6.9] and salt extraction medium (0.3 M-KI) contained deoxyribonuclease 1 (10 jug/ml), 1 mM-phenylmethanesulphonyl fluoride (PMSF) and 50 #M-leupeptin. The final insoluble pellet was collected by centrifugation as before and washed briefly with distilled water.
Density gradient fractionation of cells
Confluent monolayers of cells grown on three to nine Petri dishes (100 mm diameter) were washed in phosphate-buffered saline (PBS) followed by a wash in homogenization medium (0.25 M-sucrose in 10 mM-Tris/ HCI, pH 7.4, containing 1 mM-PMSF, 1 mM-EGTA, 10 mM-iodoacetamide and 10 ,uM-haemin) at 4 'C. Cells were then scraped into 4 ml of homogenization medium at 4 'C and homogenized as described previously (Doherty et al., 1987) , and a sample (4 ml) of the entire homogenate was applied to a preformed Nycodenz gradient and centrifuged (Doherty et al., 1987) . Fractions (0.5 ml) of the centrifuged gradient were collected and stored at -20 'C until use.
Enzyme assays
Acid phosphatase (EC 3.1.3.2) and lactate dehydrogenase (EC 1.1. 1.27) were assayed as described previously (Doherty et al., 1987) , except the volumes were reduced to permit enzyme reactions to be car-ried out in 96-well microtitre plates. Absorbances were determined in an EAR 340 enzyme-linked immunosorbent assay (e.l.i.s.a.) plate reader (SLT-Labinstruments, Austria). DNA was determined as described previously (Doherty et al., 1987) . Polyacrylamide-gel electrophoresis Polyacrylamide-gel electrophoresis in the presence of SDS was carried out with large-pore (acrylamide/ bisacrylamide, 100:1) 7.5-150% (w/v) linear gradients (Doucet & Trifaro, 1988 (Haas & Bright, 1985) , and both ubiquitin-protein conjugates and free ubiquitin after autoclaving of the nitrocellulose replicas (Swerdlow et al., 1986) .
Immunoblotting
After electrophoresis nitrocellulose (0.2 or 0.45,tm pore size) replicas of gels were obtained and allowed to dry. They were autoclaved for 20 min at 120°C (Swerdlow et al., 1986) , then incubated with blocking solution [10% (w/v) milk powder or non-immune rabbit serum (sheep primary antibody) in 0.2 M-NaCl/0.05 M-Tris/ HCI, pH 7.5] before incubation with affinity-purified rabbit or sheep antibody to ubiquitin-protein conjugates (2-5 ,ug/ml, in blocking solution). After washing, bound primary antibody was detected by incubation with biotinconjugated second antibody to rabbit or sheep IgG (0.1 ,ug/ml), followed, after washing, with avidin-biotinconjugated alkaline phosphatase complex (prepared according to the manufacturer's recommendations and diluted 50-fold before use), before localization of alkaline phosphatase (Blake et al., 1984) .
Fractions from density gradients were assayed for the presence of antibody-immunoreactive material by dotblotting. An aliquot of each fraction was heated for 3 min in a boiling water bath, after mixing with an equal volume of 1 % (w/v) SDS and 10 mM-dithiothreitol in PBS, and portions of this were applied to nitrocellulose with a 96-well manifold apparatus. Probing with antibody was carried out as described above and immunoblots or electrotransfers were scanned at 600 nm with a Quickscan R&D (Helena Laboratories, TX, U.S.A.) in reflectance mode.
Immunohistochemistry
Cells were grown on glass coverslips and fixed for 10min with 2.5% (v/v) formaldehyde in PBS. They were permeabilized with 0.1% (w/v) Triton X-100 in PBS containing glycine (100 mg/ml), and blocked for 1 h in 10% (v/v) non-immune goat serum in PBS before incubation with affinity-purified rabbit antibody to ubiquitin-protein conjugates [1:20 in PBS containing non-immune goat serum and 0.1 % (w/v) Tween 20] for 1 h. After washing off excess antibody, bound antibody was detected as described for Western blots. Cells were lightly counterstained with haematoxylin.
Immunogold electron microscopy Cells were removed from plastic Petri dishes with trypsin, diluted with medium containing serum, then washed with PBS before fixation in 1.5% (w/v) paraformaldehyde/I % (v/v) 
RESULTS

Effects of proteolytic inhibitors on the degradation of long-lived polypeptides
The effects of various cysteine proteinase inhibitors on the degradation of long-lived proteins in 3T3-L1 cells either alone or in combination with ammonium chloride are shown in Table 1 . The concentrations employed in Table 1 were above those required to give maximal inhibition of protein degradation (Doherty et al. 1989 ). Z-Phe-Phe-CHN2 formed an insoluble precipitate above 20 /M in the medium. All the inhibitors tested in Table 1 produced inhibition ofdegradation of 30-40 %. Addition of ammonium chloride along with inhibitor produced very small increases in inhibition, suggesting that the action of these inhibitors is on an ammonium chloridesusceptible, i.e. lysosomal, mechanism. Rates of protein turnover in control cells were 1.20-1.35%/h.
The inhibitors described above were tested for their ability to inhibit the action of the lysosomal cathepsins B and L. In agreement with others (Shaw & Dean, 1980) , extracts of cells cultured for 24 h with E-64 (500 /M) and Z-Phe-Ala-CHN2 (100 /M) showed little or no ability to hydrolyse Z-Phe-Arg-7-aminomethylcoumarin (< 5 % of control cells; Doherty et al., 1989) , a substrate for cathepsins B and L. A small amount (25 %) of activity was left in extracts of Z-Phe-Phe-CHN2-treated cells and even less in extracts of chloroquine-treated cells (17.5%). The effects of E-64 and the diazomethanes were only observable after several hours (Doherty et al., 1989; Shaw & Dean, 1980) and is consistent with their entry into the cell by pinocytosis where they accumulate in lysosomes (Shaw & Dean, 1980) .
Ubiquitin-protein conjugates in inhibitor-treated and untreated cells
Autoclaving of nitrocellulose replicas enabled the detection of free ubiquitin as well as conjugated ubiquitin in cell extracts ( Fig. 1 ; Swerdlow et al., 1986) . Detection of bound antibody with alkaline phosphatase revealed the presence of a variety of ubiquitin-polypeptide conjugates, as well as free ubiquitin, in whole-cell extracts of treated and untreated cells (Fig. 1, lanes a, c and e) . Discrete antibody-positive bands can be identified corresponding to ubiquitin monomer (Ub, Fig. 1 , lanes a, c and e); a doublet around 15 kDa (clearly seen in lane e, but also visible in lanes a and c); an intense band of approximately 23 kDa, and a doublet around 29 kDa (Fig. 1, lanes a, c and e ). In addition, there is a large A nitrocellulose replica of the gel was autoclaved and probed with an affinity-purified rabbit antibody against ubiquitin-protein conjugates. u-H2A (23 kDa) indicates the ubiquitinated histone H2A. Ub, a ubiquitin standard and HMW Ub conj., ubiquitin-protein conjugates of high molecular mass. (g) E-64-treated cells incubated with affinity-purified ubiquitin-protein conjugate specific antibody pre-absorbed with ubiquitin-y-globulin. smear of antibody-positive reaction product from the 40 kDa region of the gel to the top of the resolving gel (HMW Ub conj.; Fig. 1, lanes a, c and e) . This pattern of ubiquitin-containing proteins is similar to that obtained by others when 125I-labelled ubiquitin was introduced into permeabilized HTC cells (Raboy et al., 1986) and microinjected into HeLa cells . The antibody-positive band at 23 kDa has been suggested to contain the ubiquitinated histone H2A (Fig. 1, u-H2A) , while that at 29 kDa may contain the di-ubiquitinated variant (Raboy et al., 1986) . The intensity of the 23 kDa (u-H2A) band was unchanged in E-64-and ammonium chloride-treated cells as compared with control cells (Fig. 1, lane (Doherty et al. 1987) . The detergent-and salt-insoluble fractions contain little antibody-positive staining material (Fig. 1, lanes b  and d) , except in the case of cells treated for 48 h with E-64 (Fig. 1, lane J) , where a smear of higher molecular mass material (35-200 kDa, HMW Ub conj.) was present. Staining of the ubiquitin monomer band increased in both E-64-and ammonium chloride-treated cells (Fig. 1, lanes c and e versus a; 3-fold in both cases when normalized with respect to u-H2A). Incubation of the affinity-purified antibody to ubiquitin-protein conjugates with ubiquitin-y-globulin conjugate (1O ,tg/ml), before incubation with the nitrocellulose replica, abolished subsequent staining in E-64-treated cells (Fig. 1,  lane g versus e) , indicating that antibody staining was specific for ubiquitin and ubiquitin-protein conjugates. These results suggest that incubation of cells with E-64 leads to an increase in ubiquitin-protein conjugates of high molecular mass, some of which are detergent and salt insoluble. Distribution of ubiquitin-protein conjugates Dot-immunoblotting of density gradient fractions of cells incubated for 48 h with E-64 demonstrated a dramatic increase in ubiquitin-containing material (Fig. 2 , filled circles in b versus a) in fractions containing acid phosphatase activity (Fig. 2, open circles) . This confirms the suggestion that ubiquitin and ubiquitin-protein conjugates (Fig. 1) are found in the lysosomal fraction of inhibitor-treated cells. There was also an increase in immunoreactive material at the top of the gradient, comprising the soluble and plasma membrane cell components (Fig. 2b, filled circles) . This may reflect an increase of cytosolic ubiquitin-protein conjugates or free ubiquitin (which does occur; Fig. 1 , lane e). Acid phosphatase activity increased on treatment of cells with E-64 (Fig. 2, open circles) ; this is probably due to an increase in the volume of the acidic vesicular compartment in inhibitor-treated cells (Fig. 5) . Lysosomally related multivesicular dense bodies were found to increase from less than 0.5 to 60% of the fractional volume of cytoplasm after only 12 h treatment with E-64 (Doherty et al., 1989) . In previous experiments we have reported that the lysosomal enzymes N-acetylhexosaminidase and ,I-galactosidase co-distribute with acid phosphatase on Nycodenz gradients of 3T3-L1 cells (Doherty et al., 1987) .
That there was an increase in conjugated ubiquitin in the gradient fractions containing lysosomal enzyme activity was confirmed by analysis of density gradient fractions by gel electrophoresis followed by immunoblotting. The soluble fractions of untreated cells contained ubiquitin-protein conjugates (Fig. 3a , fractions 1-8) and ubiquitinated histone (u-H2A) was present in the fractions containing nuclei (N, Fig. 3a , fractions 23-24). The apparent increase in ubiquitinated histone seen in E-64-treated cells in this experiment is in contrast to the lack of an increase in this conjugate seen in Fig. 1 . Several other experiments similar to that reported in Fig.  1 demonstrated a lack ofincrease of ubiquitinated histone H2A in E-64-treated cells. The apparent increase seen in Fig. 3 could therefore be an artefact owing to incomplete electrotransfer from the resolving acrylamide gel or insufficient mixing with the primary antibody; however, we cannot rule out an E-64-induced increase in histone ubiquitination. were applied to nitrocellulose and after autoclaving probed with the affinity-purified antibody to ubiquitin-protein conjugates. After visualization, dots were scanned by reflectance densitometry to determine antibody-reactive material (@). Acid phosphatase (0) was determined in each fraction and is expressed as a percentage of the total activity in the homogenate at the start of the 48 h chase period.
Cells incubated for 48 h with E-64 were found to contain increased levels of ubiquitin-protein conjugates in fractions containing cytosolic proteins and fractions containing lysosomal enzyme activity (Fig. 3b , fractions 1-8 and fractions 15-22), while conjugates were almost absent-from the denser lysosomal fractions of control cells (Fig. 3a, fractions 15-22) . Free ubiquitin could be found in the denser lysosome fractions of control cells which increased substantially when cells were treated with E-64 (Fig. 3a versus b, fractions 15-22) . Light microscopy and ubiquitin-protein conjugate immunocytochemistry Antibody reaction product was apparent in the nucleus of fixed and permeabilized 3T3-LI cells (Fig. 4a) , while the cytoplasm contained only very low levels of reaction product. The lack of uniform staining of the cytoplasm suggests that cytosolic ubiquitin monomer is not detected under these conditions (Riley et al., 1988 (b) in the presence of E-64 (0.5 mM). Ubiquitin-protein conjugates were detected in fixed cells with rabbit antibody specific for ubiquitin-protein conjugates and visualized as described in Materials and methods. When rabbit anti-(muscle LDH) replaced anti-ubiquitin as a control for the specificity of antibody, there was little or no staining (not shown). Bar, 10 ,um. Arrows, punctate cytoplasmic reaction product. cells for 48 h with E-64 leads to the appearance of numerous aggregates of antibody reaction product in the cytoplasm (Fig. 4b, arrows) . Cells were found to contain a similar distribution of large amounts of ubiquitinpositive material when treated with the diazomethane proteinase inhibitors Z-Phe-Ala-CHN2 and Z-Phe-Phe-CHN2 (Doherty et al., 1989) and also when cells were treated with chloroquine (Doherty et al., 1989 ). In contrast, ammonium chloride-treated cells were found to contain lower levels of ubiquitin conjugates (Doherty et al., 1989 ).
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Immunogold electron microscopy of ubiquitin-protein conjugates Electron micrographs of E-64-treated cells revealed the presence of numerous multivesicular dense bodies (Fig. 5a ) which were absent from untreated cells (not shown). Some of the many individual vesicles which are found inside the enveloping membrane of these bodies appear to originate from invaginations of this membrane (Fig. 5a, arrow) and are strongly suggestive of the involvement of these bodies in microautophagy (Ahlberg Glaumann, 1985; Dice, 1987) and contrast with the formation of autophagic vacuoles seen in macroautophagy (Seglen et al., 1985) . E-64-generated dense bodies were also found to contain ubiquitin-protein conjugates as determined by immunogold electron microscopy ( Fig. Sb and Sc) , thus confirming the biochemical observations, indicated in Figs. 1-3 , that ubiquitin-protein conjugates accumulate in the lysosomal system. Gold particles were seen close to the invaginating membrane of dense bodies, and even in an invagination (Fig. Sb, arrow with star) , again suggesting that uptake into these bodies of ubiquitin-protein conjugates is by microautophagy. Ubiquitin-protein conjugates were also detected in the nucleus, Golgi and diffusely in the cytoplasm by this method (Fig. Se and Sf). Immunogold electron microscopy of reticulocytes demonstrated that the antibody specific for ubiquitinprotein conjugates bound to aggregates in the reticulocyte cytoplasm (Laszlo et al., 1989, unpublished work) , while the rest of the cytoplasm, which contains large amounts of free ubiquitin, remained unlabelled confirming that free ubiquitin is not detected under these conditions (Riley et al., 1988) .
DISCUSSION
Mode of action of inhibitors
In this study we have shown that inhibitors of cysteine cathepsins inhibit lysosomal proteolysis in confluent mouse fibroblasts. There is no evidence that any of these membrane-impermeant inhibitors (Shoji-Kasai et al., 1988) are acting on extra-lysosomal proteinases, as judged by the small additive effects of ammonium chloride when added alongside these inhibitors (Table 1) . Polypeptides destined for lysosomal degradation are sequestered in a detergent-and salt-insoluble form, and continue to accumulate in the lysosomal system in the presence of cysteine proteinase inhibitors (Doherty et al., 1987 (Doherty et al., , 1989 ; therefore, sequestration can occur even when subsequent proteolysis is prevented. Cysteine proteinases would appear to have a very important role in the degradation of proteins in the lysosome (Grinde & Seglen, 1980; Shaw & Dean, 1980; Grinde, 1983) .
Ubiquitin conjugation and lysosomal proteolysis
Incubation of cells for a relatively long period with E-64 resulted in the accumulation of ubiquitin-protein conjugates of high molecular mass, some of which were detergent and salt insoluble (Fig. 1) , which cofractionated with acid phosphatase-positive lysosomerelated vesicles on density gradient centrifugation (Figs. 2 and 3) . The presence of ubiquitin-protein conjugates in these lysosomal fractions is surprising as ubiquitin conjugation is not thought to be involved in lysosomal proteolysis, and the inhibitors used appear to act only on the lysosomal system. Bovine thymus isopeptidase is unaffected by E-64 (Kanda et al., 1986) and we have found that the disassembly of "25I-labelled ubiquitin-protein conjugates by isopeptidase action in a Fraction II (McGuire et al., 1988 ) from 3T3-LI cytosol is not prevented by E-64 (Doherty et al., 1989) . Ubiquitin-protein conjugates in reticulocytes can be degraded by a soluble proteinase of large molecular mass, which although thiol dependent, is not inhibitable by leupeptin or antipain (Hough et al., 1987) , both of which lead to the accumulation of conjugates in 3T3-L1 cells (Doherty et al., 1989) . A similar enzyme from BHK 21/C13 fibroblasts is inhibitable by 50-80 % by E-64 or leupeptin, but only at concentrations of 5 mm (McGuire et al., 1988) , 10-fold higher than employed in these studies. Therefore, it would seem that the accumulation of ubiquitin-protein conjugates seen in E-64-treated 3T3-L1 cells is not due to the inhibition of either cytosolic deconjugating activity or a soluble ubiquitin-protein conjugate ATP-dependent proteinase activity. The failure of ammonium chloride to cause the same degree of accumulation of ubiquitinprotein conjugates ( Fig. 1 and Doherty et al., 1989) , may be due to incomplete inhibition by ammonium chloride of a lysosomal activity capable of degradation of the non-ubiquitin moiety of ubiquitin-protein conjugates or of disassembly of conjugates.
We have looked at the cellular localization of aggregates containing ubiquitin-protein conjugates using immunohistochemistry and immunogold electron microscopy. E-64-treated cells (Fig. 4b ) accumulate multivesicular dense bodies (Fig. Sa-c) which are membranebordered organelles related to lysosomes (Ahlberg & Glaumann, 1985) , and which appear to contain ubiquitin-protein conjugates (Fig. Sb and c) . The interesting question is how ubiquitin-protein conjugates can enter this cell compartment. Ubiquitin is found at the cell surface conjugated to several receptor proteins (Siegelman et al., 1986; Yarden et al., 1986; Meyer et al., 1986) and plasma membrane proteins are thought to be degraded largely by lysosomal mechanisms (Tweto & Doyle, 1976) ; therefore, these ubiquitin-protein conjugates may be degraded lysosomally and would accumulate when lysosomal proteolysis of the plasma membrane is inhibited. Alternatively, ubiquitin-protein conjugates formed in the cytosol (e.g. Fig. 5c ; double arrow) could be taken up into multivesicular bodies by microautophagy as suggested by the electron micrographs shown here ( Fig. 5a-c ). There appears to be an increase in ubiquitin-protein conjugates in the cytosolic fractions from E-64-treated cells (Fig. 2 , fractions 1-8 and Fig. 3 , fractions 1-8), which could be due to slowed uptake of cytoplasmic material into the constipated lysosomal system in inhibitor-treated cells. Free ubiquitin is not thought to be degraded lysosomally (Haas & Bright, 1987) ; therefore, its apparent occurrence in the lysosomal system (Fig. 3, a versus b,  fractions 15-22) suggests that it may have entered the lysosomal system in conjugated form and been released after degradation of the target protein or hydrolysis of the isopeptide bond. Ubiquitin is remarkably resistant to both low pH (Lenkinski et al., 1977) and proteolytic digestion (Schlesinger et al., 1975) and therefore could accumulate in the lysosome. The increase in ubiquitinprotein conjugates in the lysosomal sysem (Fig. 3) could therefore be an underestimate of the amount of ubiquitin-protein conjugates that have entered the lysosome, owing to lysosomal isopeptidase activity or incomplete inhibition of lysosomal proteolysis. lodoacetamide and haemin were included in the homogenization medium to inhibit isopeptidase (Vierstra & Sullivan, 1988) and ATP-and ubiquitin-dependent proteinase action (Hough et al., 1987) during the fractionation procedure.
We are not able to say whether uptake of ubiquitinprotein conjugates into the lysosomal system is faster than that of unconjugated proteins, i.e. that ubiquitination leads to enhanced lysosomal sequestration. It has been suggested that the relatively hydrophobic Nterminus of ubiquitin may act as a signal for membrane translocation (Wilkinson, 1987) . Alternatively, ubiquitination may lead to partial unfolding of target proteins exposing hydrophobic sites which bind to lysosomal membranes and are subsequently taken up by microautophagy. Ubiquitination may act as a signal for membrane invagination as seen during microautophagy in multivesicular bodies (Figs. 5a and b) . Ubiquitin has been found to be secreted from cultured cells (Haas & Bright, 1987; and free ubiquitin is found relatively concentrated in lysosomes and autophagic vacuoles of hepatoma cells (Schwartz et al., 1988) compared with the surrounding cytoplasm. Therefore, ubiquitin must be able to find its way into vesicular cell compartments, possibly in conjugated form.
Lysosomal inhibitors have been reported to lead to an increase in expression of some heat shock genes (Hsp 70; Ananthan et al., 1986 ) and the polyubiquitin gene in chicken and human fibroblasts is also subject to a heat shock promoter (Bond & Schlesinger, 1985; Choi et al., 1988) . We have found that ammonium chloride and chloroquine lead to a small increase, and E-64 a large increase, in the transcription of a polyubiquitin gene in 3T3-L1 cells (Doherty et al., 1989) . Therefore, lysosomal inhibitors, particularly inhibitors of lysosomal cysteine proteinases, may lead not only to the accumulation of ubiquitin-protein conjugates, but also to an increase in ubiquitin gene expression to provide free ubiquitin for increased ubiquitination of cytoplasmic proteins.
We have recently provided evidence that intermediate filament-containing inclusions in chronic degenerative (Lowe et al., 1988a-c; Lennox et al., 1989 ) and viral diseases (Lowe et al., 1988d) are ubiquitinated. In Alzheimer's disease we have shown that in areas of granulovacuolar degeneration in hippocampal neurones (Lowe et al., 1988a) , the granular material in membranelimited vacuoles is ubiquitinated, i.e. intravesicular material is ubiquitinated in a chronic neurodegenerative disease. It is possible that the intravesicular accumulation of ubiquitin-protein conjugates in E-64-treated cells provides a model for this phenomenon.
